Pages that link to "Q77323458"

The following pages link to Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women (Q77323458):

Displaying 19 items.

• The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats (Q32090066) (← links)
• The mechanisms of thrombotic risk induced by hormone replacement therapy (Q34421664) (← links)
• Hormone replacement therapy at the threshold of 21st century (Q34491410) (← links)
• Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women (Q36383775) (← links)
• Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women (Q40632178) (← links)
• Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women (Q42487474) (← links)
• Duration of menopause and behavior of malondialdehyde, lipids, lipoproteins and carotid wall artery intima-media thickness. (Q43672787) (← links)
• Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy (Q43786652) (← links)
• Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women (Q43813819) (← links)
• Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women (Q43901211) (← links)
• The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial (Q44205516) (← links)
• Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women (Q44244537) (← links)
• Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study (Q44317930) (← links)
• Does the beneficial effect of HRT on endothelial function depend on lipid changes (Q44445612) (← links)
• Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women (Q44489365) (← links)
• Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? (Q44770881) (← links)
• Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users (Q73849738) (← links)
• Cardiovascular protection by postmenopausal hormone replacement therapy -- the point of lower oestrogen dosages (Q73893653) (← links)
• Association of postmenopausal hormone replacement therapy with carotid atherosclerosis and soluble thrombomodulin: the vascular aging (EVA) study. Etude du Vieillissement Artériel (Q74180629) (← links)